AAAAAA

   
Results: 1-17 |
Results: 17
ORAL ANTIPLATELET EFFICACY AND SPECIFICITY OF A NOVEL NONPEPTIDE PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-802/
Authors: MOUSA SA OLSON RE BOZARTH JM LORELLI W FORSYTHE MS RACANELLI A GIBBS S SCHLINGMAN K BOZARTH T KAPIL R WITYAK J SIELECKI TM WEXLER RR THOOLEN MJ SLEE A REILLY TM ANDERSON PS FRIEDMAN PA
Citation: Sa. Mousa et al., ORAL ANTIPLATELET EFFICACY AND SPECIFICITY OF A NOVEL NONPEPTIDE PLATELET GPIIB IIIA RECEPTOR ANTAGONIST, DMP-802/, Journal of cardiovascular pharmacology, 32(2), 1998, pp. 169-176
DISSOCIATION BETWEEN THE ANTI-AGGREGATORY AND ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN ALPHA-IIB-BETA-3 (GPIIB IIIA) ANTAGONISTS, C7E3 AND DMP728 (VOL 88, PG 137, 1997)/
Authors: TSAO PW FORSYTHE MS MOUSA SA
Citation: Pw. Tsao et al., DISSOCIATION BETWEEN THE ANTI-AGGREGATORY AND ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN ALPHA-IIB-BETA-3 (GPIIB IIIA) ANTAGONISTS, C7E3 AND DMP728 (VOL 88, PG 137, 1997)/, Thrombosis research, 89(2), 1998, pp. 97-97
ANTIPLATELET EFFICACY OF XV459, A NOVEL NONPEPTIDE PLATELET GPIIB IIAANTAGONIST - COMPARATIVE PLATELET BINDING PROFILES WITH C7E3/
Authors: MOUSA SA BOZARTH JM LORELLI W FORSYTHE MS THOOLEN MJMC SLEE AM REILLY TM FRIEDMAN PA
Citation: Sa. Mousa et al., ANTIPLATELET EFFICACY OF XV459, A NOVEL NONPEPTIDE PLATELET GPIIB IIAANTAGONIST - COMPARATIVE PLATELET BINDING PROFILES WITH C7E3/, The Journal of pharmacology and experimental therapeutics, 286(3), 1998, pp. 1277-1284
DISSOCIATION BETWEEN THE ANTI-AGGREGATORY AND ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN ALPHA(IIB)BETA(3) (GPIIB IIIA) ANTAGONISTS, C7E3 AND DMP728/
Authors: TSAO PW FORSYTHE MS MOUSA SA
Citation: Pw. Tsao et al., DISSOCIATION BETWEEN THE ANTI-AGGREGATORY AND ANTI-SECRETORY EFFECTS OF PLATELET INTEGRIN ALPHA(IIB)BETA(3) (GPIIB IIIA) ANTAGONISTS, C7E3 AND DMP728/, Thrombosis research, 88(2), 1997, pp. 137-146
XV454, A NOVEL NONPEPTIDE ANTIPLATELET AGENT WITH COMPARABLE PLATELETALPHA-IIB-BETA-3 BINDING-KINETICS TO C7E3 AND LONG-LASTING ANTIPLATELET EFFICACY AFTER SINGLE INTRAVENOUS OR ORAL-ADMINISTRATION IN NONHUMAN-PRIMATES
Authors: MOUSA SA BOZARTH JM FORSYTHE MS THOOLEN M REILLY TM WITYAK J OLSON RE SIELECKI TM
Citation: Sa. Mousa et al., XV454, A NOVEL NONPEPTIDE ANTIPLATELET AGENT WITH COMPARABLE PLATELETALPHA-IIB-BETA-3 BINDING-KINETICS TO C7E3 AND LONG-LASTING ANTIPLATELET EFFICACY AFTER SINGLE INTRAVENOUS OR ORAL-ADMINISTRATION IN NONHUMAN-PRIMATES, Circulation, 96(8), 1997, pp. 928-928
THROMBOLYTIC AND ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP728/
Authors: REILLY TM FORSYTHE MS LUCCHESI BR MOUSA SA
Citation: Tm. Reilly et al., THROMBOLYTIC AND ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB IIIA ANTAGONIST DMP728/, The FASEB journal, 9(4), 1995, pp. 837-837
PLATELET GPIIB IIIA RECEPTOR OCCUPANCY STUDIES USING A NOVEL FLUORESCEINATED CYCLIC ARG-GLY-ASP PEPTIDE/
Authors: TSAO PW BOZARTH JM JACKSON SA FORSYTHE MS FLINT SK MOUSA SA
Citation: Pw. Tsao et al., PLATELET GPIIB IIIA RECEPTOR OCCUPANCY STUDIES USING A NOVEL FLUORESCEINATED CYCLIC ARG-GLY-ASP PEPTIDE/, Thrombosis research, 77(6), 1995, pp. 543-556
INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY DMP757, A NOVEL PLATELET GPIIB IIIA ANTAGONIST/
Authors: MOUSA SA DEGRADO WF JACKSON S FLINT SK FORSYTHE MS REILLY TM
Citation: Sa. Mousa et al., INTRAVENOUS AND ORAL ANTIPLATELET ANTITHROMBOTIC EFFICACY AND SPECIFICITY DMP757, A NOVEL PLATELET GPIIB IIIA ANTAGONIST/, Circulation, 92(8), 1995, pp. 2332-2332
THROMBOLYTIC AND ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB-IIIA ANTAGONIST DMP728
Authors: MOUSA SA FORSYTHE MS DIEMER M BOZARTH JM REILLY TM
Citation: Sa. Mousa et al., THROMBOLYTIC AND ANTITHROMBOTIC EFFICACY OF THE PLATELET GPIIB-IIIA ANTAGONIST DMP728, Coronary artery disease, 5(11), 1994, pp. 919-927
ANTIPLATELET AND ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELETGPIIB IIIA RECEPTOR ANTAGONIST/
Authors: MOUSA SA BOZARTH JM FORSYTHE MS JACKSON SM LEAMY A DIEMER MM KAPIL RP KNABB RM MAYO MC PIERCE SK DEGRADO WF THOOLEN MJ REILLY TM
Citation: Sa. Mousa et al., ANTIPLATELET AND ANTITHROMBOTIC EFFICACY OF DMP-728, A NOVEL PLATELETGPIIB IIIA RECEPTOR ANTAGONIST/, Circulation, 89(1), 1994, pp. 3-12
PROTECTIVE EFFECT OF VITRONECTIN ON OXIDANT-INDUCED INACTIVATION OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (RPAI-1) - STRUCTURAL AND FUNCTIONAL-ANALYSIS
Authors: MOUSA SA FORSYTHE MS DWIVEDI AM REILLY TM
Citation: Sa. Mousa et al., PROTECTIVE EFFECT OF VITRONECTIN ON OXIDANT-INDUCED INACTIVATION OF RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 (RPAI-1) - STRUCTURAL AND FUNCTIONAL-ANALYSIS, Biochemical archives, 9(3), 1993, pp. 205-216
EFFECT OF SINGLE ORAL DOSE OF ASPIRIN ON HUMAN PLATELET FUNCTIONS ANDPLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
Authors: MOUSA SA FORSYTHE MS BOZARTH JM REILLY TM
Citation: Sa. Mousa et al., EFFECT OF SINGLE ORAL DOSE OF ASPIRIN ON HUMAN PLATELET FUNCTIONS ANDPLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1), Thrombosis and haemostasis, 69(6), 1993, pp. 903-903
COMPARATIVE ANTIPLATELET EFFECTS OF DIFFERENT THROMBIN INHIBITORS - KINETIC-ANALYSIS
Authors: MOUSA SA BOZARTH JM MAYO MC FORSYTHE MS REILLY TM
Citation: Sa. Mousa et al., COMPARATIVE ANTIPLATELET EFFECTS OF DIFFERENT THROMBIN INHIBITORS - KINETIC-ANALYSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 1070-1070
ANTIPLATELET EFFECTS OF THROMBIN INHIBITORS VERSUS GPIIB IIIA RECEPTOR ANTAGONISTS - COMPARATIVE KINETIC AND MECHANISTIC ANALYSIS/
Authors: MOUSA SA MAYO MC BOZARTH JM FORSYTHE MS REILLY TM
Citation: Sa. Mousa et al., ANTIPLATELET EFFECTS OF THROMBIN INHIBITORS VERSUS GPIIB IIIA RECEPTOR ANTAGONISTS - COMPARATIVE KINETIC AND MECHANISTIC ANALYSIS/, Thrombosis and haemostasis, 69(6), 1993, pp. 1321-1321
RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROTECTS PLATELETS AGAINST THE INHIBITORY EFFECTS OF PLASMIN
Authors: REILLY TM FORSYTHE MS RACANELLI AL SPITZ SM WALTON HL MOUSA SA
Citation: Tm. Reilly et al., RECOMBINANT PLASMINOGEN-ACTIVATOR INHIBITOR-1 PROTECTS PLATELETS AGAINST THE INHIBITORY EFFECTS OF PLASMIN, Thrombosis research, 71(1), 1993, pp. 61-68
EFFECT OF SINGLE ORAL DOSE OF ASPIRIN ON HUMAN PLATELET FUNCTIONS ANDPLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1
Authors: MOUSA SA FORSYTHE MS BOZARTH JM REILLY TM
Citation: Sa. Mousa et al., EFFECT OF SINGLE ORAL DOSE OF ASPIRIN ON HUMAN PLATELET FUNCTIONS ANDPLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1, Cardiology, 83(5-6), 1993, pp. 367-373
ANTIPLATELET EFFICACY AND SPECIFICITY OF DMP728, A NOVEL PLATELET GPIIB IIIA RECEPTOR ANTAGONIST/
Authors: MOUSA SA BOZARTH JM FORSYTHE MS LORELLI W THOOLEN MJ RAMACHANDRAN N JACKSON S DEGRADO W REILLY TM
Citation: Sa. Mousa et al., ANTIPLATELET EFFICACY AND SPECIFICITY OF DMP728, A NOVEL PLATELET GPIIB IIIA RECEPTOR ANTAGONIST/, Cardiology, 83(5-6), 1993, pp. 374-382
Risultati: 1-17 |